Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 25 stocks Jim Cramer recently shared insights on. While discussing drug ...

Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...

Procurement is evolving beyond sourcing as it faces macroeconomic and supply chain challenges.BI Live will host a virtual event on July 30 titled Resilient Growth: Navigating Procurement ...

Bristol Myers Squibb to cut 68 jobs in Lawrenceville as part of a broader restructuring effort aiming to slash $2B in costs ...

Two months after Bristol Myers Squibb fended off a lawsuit which accused the drugmaker of using illegal tactics to protect ...

Looking into the current session, Bristol-Myers Squibb Inc. BMY shares are trading at $47.05, after a 1.22% drop. Over the ...

This Big Pharma company is positioned for a rebound while continuing to pay investors a sizable dividend yield.

Review Bristol-Myers Squibb Co (BMY:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.